Subscribe To
RPTX / Repare Therapeutics to Participate in Two Upcoming Virtual Investor Conferences
Content Topics
Shun
Ho
Property
Investments
Limited
0219
Hk
Repare
Therapeutics
Participate
Upcoming
Virtual
Investor
Conferences
Stock
RPTX
RPTX News
By Zacks Investment Research
October 11, 2023
Down -25.05% in 4 Weeks, Here's Why Repare Therapeutics Inc. (RPTX) Looks Ripe for a Turnaround
Repare Therapeutics Inc. (RPTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, comb more_horizontal
By Zacks Investment Research
October 9, 2023
Here's Why Repare Therapeutics Inc. (RPTX) is Poised for a Turnaround After Losing -26.14% in 4 Weeks
The heavy selling pressure might have exhausted for Repare Therapeutics Inc. (RPTX) as it is technically in oversold territory now. In addition to thi more_horizontal
By Zacks Investment Research
September 20, 2023
Strength Seen in Repare Therapeutics Inc. (RPTX): Can Its 12.2% Jump Turn into More Strength?
Repare Therapeutics Inc. (RPTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions mi more_horizontal
By The Motley Fool
August 16, 2023
Wall Street Thinks This Cathie Wood Stock Could Jump by 187%
Cathie Wood's ARK Genomic Revolution ETF is a top shareholder of Repare Therapeutics. Wood, along with several Wall Street analysts, hold an overtly b more_horizontal
By Zacks Investment Research
May 9, 2023
Repare Therapeutics Inc. (RPTX) Reports Q1 Loss, Misses Revenue Estimates
Repare Therapeutics Inc. (RPTX) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compare more_horizontal
By Zacks Investment Research
May 3, 2023
How Much Upside is Left in Repare Therapeutics Inc. (RPTX)? Wall Street Analysts Think 214.72%
The mean of analysts' price targets for Repare Therapeutics Inc. (RPTX) points to a 214.7% upside in the stock. While this highly sought-after metric more_horizontal
By Zacks Investment Research
February 28, 2023
Repare Therapeutics Inc. (RPTX) Reports Q4 Loss, Tops Revenue Estimates
Repare Therapeutics Inc. (RPTX) delivered earnings and revenue surprises of -2.74% and 84.75%, respectively, for the quarter ended December 2022. Do t more_horizontal
By Zacks Investment Research
December 2, 2022
Repare Therapeutics Inc. (RPTX) Just Overtook the 20-Day Moving Average
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average? more_horizontal